Reticulocalbin-3 activators pertain to a specialized class of chemical compounds that interact with reticulocalbin-3, a member of the CREC family of proteins, which is characterized by the presence of multiple EF-hand domains, typically associated with calcium-binding. The molecular structure of reticulocalbin-3 suggests its involvement in calcium-dependent processes within the endoplasmic reticulum, where it is predominantly located. Reticulocalbin-3 activators are compounds that can modulate the function of reticulocalbin-3 by altering its conformation, stability, or its interaction with other proteins and ions. The precise mechanism by which these activators exert their influence can vary significantly, ranging from direct binding to the protein, mimicking natural ligands, or indirectly affecting its environment to stabilize the protein and promote its activity.
The exploration and identification of reticulocalbin-3 activators are rooted in extensive biochemical and pharmacological research. Such compounds are often discovered through high-throughput screening assays, where large libraries of small molecules are tested for their ability to bind or modulate the activity of reticulocalbin-3. Structural analogs of natural ligands or compounds identified through computational chemistry approaches are also potential sources of reticulocalbin-3 activators. Once identified, these activators are subjected to further studies to decipher their interaction at the molecular level, which includes assessing binding affinity, specificity, and the resultant conformational changes in reticulocalbin-3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases cytosolic calcium by transporting calcium across biological membranes, potentially enhancing reticulocalbin-3 activation to buffer these changes. | ||||||
L-phenylephrine | 59-42-7 | sc-295315 sc-295315A | 5 g 25 g | $181.00 $492.00 | 2 | |
Increases intracellular calcium by activating α-adrenergic receptors. Reticulocalbin-3 activation might be enhanced to modulate this rise. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Modulates calcium release through ryanodine receptors, potentially necessitating increased reticulocalbin-3 activity to buffer the effects. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Inhibits voltage-dependent calcium channels, modulating intracellular calcium, and might induce an adaptive increase in reticulocalbin-3 activity. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Inhibits SERCA, depleting ER calcium and potentially inducing a compensatory response involving reticulocalbin-3. | ||||||